The purpose of this clinical research study is to assess the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
50
Tablets, Oral, 1-10mg, Once daily, 6 weeks.
Local Institution
Albany, New York, United States
Tolerability
Safety Assessments
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.